Blog
Developing Neuroprotective Therapies: Defending the Nervous System from Damage
Blogthe University of Texas MD Anderson Cancer Center and Accelerator Life Science Partners recently announced the launch of Magnolia Neurosciences Corporation – a biopharmaceutical company advancing a new class of neuroprotective medicines.
Read More
Single Cell Analysis with the BD AbSeq Assay
BlogNew tools are enabling researchers to explore individual cells with unprecedented clarity, allowing RNA and protein expression levels to be simultaneously analyzed. In this blog, Brian Lilhanand, Global Platform Leader, Single Cell Multiomics, at BD, discusses how BD’s new AbSeq Assay can provide this targeted profiling and benefit immunology researchers.
Moving Past Paper: Realizing the Potential of ELNs
BlogElectronic Laboratory Notebooks are becoming more popular as labs embrace digitization. ELN provider Biodata’s flagship offering, Labguru, has over 30,000 users worldwide. We caught up with Steve Yemm, recently appointed CEO of BioData, to ask him about the advantages of ELNs and the challenges they face in a digital market.
Why is China Becoming a Microfluidics Manufacturing Superpower?
BlogMany Chinese microfluidics companies are emerging and expanding, and it could be game-changing for the industry. We spoke with Yole Développement analyst, Sébastien Clerc, to learn more.
Read More
Helping Rare Disease Reseach BeHEARD
BlogEarlier this summer, the Rare Genomics Institute announced the winners of the 2018 BeHEARD (Help Empower & Accelerate Research Discoveries) Challenge. The Challenge tasks researchers or foundations working in fields of rare disease research to apply for grants, either financial or technological, to assist their research. We caught up with the Institute’s Arvin M. Gouw to discuss the awards and the battle against rare disease.
Read More
Say Hello to Regenerative Medicine and Goodbye to Back Pain
BlogDegenerative disc diseases are debilitating, and treatment options are lacking. Three leaders from Discgenics explain how they are harnessing the restorative potential of cells native to the intervertebral disc to alleviate lower back pain.
Read More
Tackling Antibiotic-resistance: Nitric Oxide-based Treatments for Respiratory Diseases
BlogThe failure of conventional antibiotics to treat numerous antibiotic-resistant infections necessitates the development of new agents – as a natural anti-microbial nitric oxide holds particular promise.
Read More
In Vitro Systems and Inhalation Toxicology
BlogIn early July, experts from around the world met in Nice, France, to share and discuss the latest innovations and research in the context of human lung in vitro models. This blog highlights some of the topics covered during the event.
Read More
Going with the Flow
BlogThis month we sat down with Dr Omar Jina, Chief Commercial Officer at Syrris Ltd., to discuss flow chemistry, its applications and the push to raise awareness of this transformative technology.
Read More
Treating Diseases Associated with Pathogenic Proteins Expressed by Human Endogenous Retroviruses
BlogWe recently spoke to Dr. Hervé Perron, HDR, Chief Scientific Officer at GeNeuro to learn about their progress developing new treatments for neurological and autoimmune diseases associated with pathogenic proteins expressed by human endogenous retroviruses (HERVs).
Read More
